Malaria affects 216 million people worldwide — mostly younger children in sub-Saharan Africa — and causes 445,000 deaths annually. Although the mosquito-borne, parasitic disease is preventable and curable, barriers exist in diagnosing the illness. The standard blood test used for diagnosis can be cumbersome, time-consuming and expensive, and its availability is limited in settings where